DatasetName,COPB2_S(13) COPB2_S(176) COPB2_S(767) COPB2_S(787) COPB2_S(830) COPB2_S(845) COPB2_S(867) COPB2_T(15) COPB2_T(612) COPB2_T(832),COPB2_S(846) COPB2_S(859) COPB2_T(861)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.48356525436657094,
FSO2013_Ratio M/L normalized Rep3,,0.5847150273091203
SR2019_MCF7_Biol_repl_3,,0.6184425924014411
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,0.5853405149800354
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.6803119495172251
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.48017341789148904,0.6764321909877512
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5998982770186634
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.60150432644958
SR2019_MDAMB231_Biol_repl_4,,0.5797442326111754
GF2025_P2_Sph,,0.5952051893116654
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,0.5993990533861154
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.601605568276394
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.48110701209492757,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5095467070480387,
WZ2023_Pu_010_30min,,0.7198196328195802
AS2011_Ratio H/L Proteins RNAi_2,0.490322640338314,0.6079316469566137
RB2022_4_PreStrength,0.48976270539585576,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5864188751570754
RB2022_8_RecoveryEndurance,0.5025921897448664,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.4848762024704601,0.6344401346391638
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.5739697009724657
RB2022_5_PreSprint,0.4985437520586137,
PG2020_Intensity 8h_C,,0.5848905329416906
AH2018_SILAC_MR_2_N,,0.6241331273299338
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.6030179589324798
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.6014429906690861
AS2011_Ratio H/L Proteins Inhi_2,,0.5911174708581833
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.6234132413810966
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.48904334396888915,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.4857620213652968,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.49315761466142394,
GF2025_P6_Sph,,0.6237895839185773
RB2022_2_PreSprint,0.492293943427687,
ZX2022_CB treated Replicate 3,,0.5997048558565894
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.7203914471350292
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,0.7333488409083696
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.6101834470427873
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5868228128772978
WZ2023_Pu_025_30min,,0.7201650217172127
AH2018_SILAC_MR_2_X,,0.6257449247699814
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5407757654225238
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.48373352883506426,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.5942674604537418
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.6751931603211813
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.6925213117989674
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.6104794833682127
AH2018_LFQ_1_C,,0.6292698749297656
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.730713621057065
CK2022_11 40-1,,0.6116333077787832
CW2012_10 µM Erl/control Experiment 3 Replicate B,,0.6396453538171268
AH2018_SILAC_2_X,,0.6914897482287993
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.690661683617273
FSO2013_Ratio H/L normalized Rep2,,0.6011612613903391
WZ2023_Pu_005_20min,,0.7353789830359204
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5512302030322423
CW2012_10 µM Gef/control Experiment 2 Replicate B,,0.5925089166827131
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5836619219687904
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,0.610989295057739
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.4762609329105792,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.6786272733656356
CK2022_1 200-1,,0.679497647925397
PG2020_Intensity Mock_10h_D,,0.644359734650555
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.48601543995281143,0.6411322606102592
RB2022_6_RecoveryEndurance,0.4894584756693088,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.47709037039352015,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5513055709079946
PG2020_Intensity 2h_C,,0.6194824992003652
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5982537221148615
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,0.5992547794494296
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5864378166506693
CK2022_3 40-1,,0.6143344885149308
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.6701193973677251
HH2022_Reporter intensity 8,,
ZQ2022_N2,,0.6049868716479837
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.48710861284856266,0.6381322546187059
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,0.5805758992855905
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,0.618973756288225
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.6760594853760719
YA2020_Reporter_intensity_Normal_No.1,,0.6711020561077216
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.47499843509824186,
RB2022_1_PostEndurance,0.47800963708906785,
CR2017_Ratio Replicate 3,,0.5599262591307911
SR2019_Hs578T_Biol_repl_3,,0.6222380761927012
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.4993883599831485,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5893664293868727
HS2024_8_I_T3,,
CF2017_EOC 3,,0.6365252532007886
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.4793980239172081,0.5649360432130627
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.7218404855570971
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.6160515370873504
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.6255995141765642
CK2022_8 16-1,,0.6803170834196974
KS2014_Intensity N3,,0.6708384097954161
RB2022_4_RecoveryEndurance,0.4952592959819234,
RB2022_5_RecoveryEndurance,0.49153773914125043,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.47657317789968623,0.6754776607098685
FSO2013_Ratio H/M normalized Rep2,,0.5788121863898958
RAM2015_Log2 A,,0.6096143052892774
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.6840897476128219
KS2014_Intensity E15_2,,0.6960117461164176
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5880541916609346
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.6761805801681776
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.6134164341801271
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,0.680496112960198
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5100711128992623,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.6294207905877078
CW2012_10 µM Gef/control Experiment 1 Replicate A,,0.5901338690105146
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,0.4917591358038457,0.6038839161558079
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.4866501852332334,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.48929303791309947,
AH2018_SILAC_IT_3_X,0.49855730802358933,0.695036724263922
JAW2011_Ratio H/L,,0.564311675896984
PG2020_Intensity 10h_C,,0.5682765793051249
FSO2013_Ratio M/L normalized Rep2,,0.5930346635165092
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.6148927708223911
RB2022_6_PreSprint,0.49576522965665937,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.6179268733929387
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.6135282422947109
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5860894303637004
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.49930070212529076,0.6813272471685754
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5893719463633494
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.48099364729303423,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,0.6263683509280121
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.4800523482594376,0.678858606638832
JW2021_After_3,,
GF2025_P8_Sph,,0.6074021883640555
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.691829722239242
CK2022_11 200-1,,0.6712516158619805
CK2022_12 200-1,,0.6718080572379289
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,0.7178139411831955
AH2018_TMTMS2_2_N,0.48457119698019796,0.6383762867033952
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.49320195808220185,
AH2018_TMTMS3_Pool,0.48775369494186105,0.6497833469429475
KS2014_Intensity N4,0.48636940546029034,0.6783306439727294
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.598755635498231
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.650764339605823
CK2022_14 200-1,,0.6746110140250191
SR2019_Hs578T_Biol_repl_1,,0.6051654198882593
RB2022_7_PostSprint,0.4831005575071104,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4864899680107916,0.6648038296057003
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.6525024030247365
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,0.6080251989248445
CK2022_13 16-1,,0.6799438688429297
GF2025_P1_Adh,,0.6090996760364454
GF2025_P1_Sph,,0.6118834438230402
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.7438212965304315
CF2017_EOC 1,,0.6240392583945132
CK2022_3 200-1,,0.6794958447188156
AH2018_LFQ_IT_3_C,,0.6972688803432199
SR2019_Hs578T_Biol_repl_2,,0.6322151094274009
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.48131465944882407,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,0.6043568852928761
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,0.5891560015536227
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.4920380569442132,
CK2022_2 40-1,,0.6169137878178591
RB2022_1_PostSprint,0.491118823873779,
CK2022_4 200-1,,0.6788321915056178
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.6803170834196974
AR2021_ALG 1 μM,,0.5996942430781461
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,0.6045235153203318
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.5666806108995757
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5897862331037342
CK2022_9 16-1,,0.6752701918669138
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,0.49046483502730653,0.6038734986931079
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.5957125140745617
CK2022_13 200-1,,0.671832750850939
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.6167640557437998
CK2022_16 16-1,,0.6820757482350966
FS2019_db/db3,,
CK2022_15 40-1,,0.615345522789449
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.6650091839657338
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.6917895210597272
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.4839780867183361,0.6363882361246761
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.5926683507738788
KBE2022_Log2_Ex_27_U,,0.6331100439690962
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.4780161223933487,0.673535516518149
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.48385300191330083,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.48587974142410656,
YA2020_Reporter_intensity_Normal_No.4,,0.6737264773183208
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.6250460768913954
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.6795115457492327
RN2012_L13,,
LG2023_Control-1_intensity,,0.5837985847302805
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,0.5938250760083165
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5839506898757638
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.6098109064759522
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.6100412139058905
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,0.4861510288033225,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,0.48896462433513055,0.5945688779267574
KS2014_Intensity pY_N3,,0.5970781461507045
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5685178489614579
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,0.6653624402436489
AH2018_TMTMS2_3_X,0.48373656330864606,0.6300070560474724
GF2025_P3_Adh,,0.5997916577690164
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.4872429581405739,0.6590441482373928
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5484958322852888
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.48750543783954753,
LG2023_GSK3α-3_intensity,,0.5969289032742302
YA2020_Reporter_intensity_Cancer_No.1,,0.6787606552604939
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,0.5763616112769047
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5926584931718207
LG2023_Control-2_intensity,,0.62244130968902
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.5913237049519878
RB2022_5_RecoverySprint,0.48785956893912796,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.6627933957234563
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.6315037612601857
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.4830116696530079,0.6581468902580113
HH2022_Reporter intensity 1,,0.6259040028610229
HH2022_Reporter intensity 2,,0.6287529084033475
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.6782545727575403
SR2019_MCF7_Biol_repl_1,,0.6184413480257046
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.588964832773494
EP2017_Untreated R#2 log2 ratio,0.4736979211457687,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.4894280654478482,
CR2017_Ratio Replicate 2,,0.5702483666126088
CW2012_10 µM Erl/control Experiment 2 Replicate A,,0.5797358096473939
FSO2013_Ratio H/M normalized Rep3,,0.5916741569952882
AR2021_KD 72h,,0.5935314579989203
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.5948190197260516
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.4868555625786529,0.6542796602605047
KBE2022_Log2_Ex_9_U,,0.6165349164947078
AH2018_SILAC_M_3_N,,0.6761776031487874
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.62791628462071
CF2017_OSE 29,,0.6401619440325722
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.5519668446914432
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.6788605108863296
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5932094689696948
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.6196668271204814
RB2022_7_RecoveryEndurance,0.49905138753845596,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,0.5847566883098665
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.6173499404603343
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.7069334643331207
RB2022_1_PreSprint,0.49030959257674117,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.687465857729471
CK2022_5 200-1,,0.6882753156709013
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.6018146520867345
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.4889692504453782,
AH2018_LFQ_2_C,,0.621327037187881
AH2018_SILAC_MR_1_X,,0.6292815938460056
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,0.6790748577706921
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.593274060891138
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5896211084591784
CK2022_4 16-1,,0.6803016315948058
AS2011_Ratio H/L,0.48011939175689544,0.5405494791773395
SR2019_MCF7_Biol_repl_4,,0.6223356307274728
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,0.5480359018572751
JAW2011_Ratio H/L LS1a_1,,0.5761325598543066
AH2018_LFQ_1_N,,0.633350058863221
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.60791607254902
FSO2013_Ratio H/L normalized Rep3,,0.5900960451436202
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.6140025059296915
AH2018_SILAC_IT_2_N,0.49924532047079906,0.6809952392192605
AH2018_SILAC_IT_1_X,0.49844897366910723,0.7005265639815293
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.6246684207632257
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.6065285302254959
WZ2023_Pe_025_20min,,0.7262651820022757
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,0.5604567519332385
AH2018_LFQ_2_N,,0.6554417880985315
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.48461470686663566,0.6267700246593287
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,0.7314552620330682
SR2019_HCC1419_Biol_repl_4,,0.6493030971005728
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.5849981992328624
AS2011_Ratio H/L Protein,0.4917591358038457,0.6038839161558079
UK2020_HCM_3,,0.6233448597499668
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5460236013700578
WZ2023_Su_025_10min,,0.7191396066574717
AH2018_LFQ_IT_4_X,,0.675001196278318
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.7301759068062118
CW2012_10 µM Gef/control Experiment 1 Replicate B,,0.5968592162632026
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,0.6687454248030154
RB2022_1_PreEndurance,0.4887225842661274,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.5681248233638455
EP2017_Pervanadate R#1 log2 ratio,0.4957967372278175,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.47922045077975917,
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5566962892073276
LY2019_P7+,,0.6014028707740451
EP2017_Untreated R#1 normalized log2 ratio,0.5053764730695677,
RN2012_L10,,
PG2020_Intensity 4h_C,,0.6350453724432029
EP2017_Mitotic R#3 normalized log2 ratio,0.47555209969788076,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,0.4993011858640342,
AH2018_SILAC_IT_2_X,0.4985031083819436,0.6953808076020419
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.4940459705065998,0.6060040276873413
CR2017_Ratio Replicate 1.1,,0.6755022173690067
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.6717626785231979
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.45834909195771545,
GF2025_P9_Sph,,0.5912150935723743
CK2022_6 200-1,,0.6879300281162805
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.4880705962789425,0.6552250453957255
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.6068647069171353
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.5880173686595288
PG2020_Intensity 2h_D,,0.6137658581368771
EP2017_Untreated R#3 normalized log2 ratio,0.49408219665656034,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,0.580816623024043
CK2022_8 200-1,,0.688114860518653
KS2014_Intensity pY_C4,,0.6136904020001396
CR2017_Ratio Replicate 3.5,,0.6009333443867164
RB2022_7_PostEndurance,0.47744623802676245,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.464041445125188,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),0.4750514245718522,0.5261344717354892
KS2014_Intensity pY_E5_4,,0.5949310139359419
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.6960070205693324
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),0.4934138758004113,0.6046000972571672
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.6147903083782343
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,0.48896462433513055,0.5945688779267574
CW2012_10 µM Gef/control Experiment 3 Replicate B,,0.6050130434187042
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,0.5958087797575358
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.4761992287512499,
AH2018_SILAC_MR_3_N,,0.6200129974434603
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.6521737317116698
PG2020_Intensity CT_C,,0.6359046366161386
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.5738791764125039
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.49468887990935223,
RB2022_2_PostStrength,0.4959947230395339,
AS2011_Ratio H/L Normalized_1,0.48722151366566957,0.5965949066161991
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5821775687795343
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.47701433040041286,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,0.5801547564303865
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.4907115733510004,
CR2017_Ratio Replicate 2.3,,0.5589142691527579
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.6134570604646555
YA2020_Reporter_intensity_Normal_No.2,,0.6737108239740407
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.620113125649121
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.6690853908611754
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.67995383441861
RAM2015_Log2 B,,0.6337839834943007
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.6241345503457457
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,0.5480359018572751
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.6454905587775682
WZ2023_Su_025_30min,,0.7187321249220058
AH2018_LFQ_4_N,,0.6113363813137521
CR2017_Ratio Replicate 1.2,,0.6146033126404389
AS2011_Ratio H/L Normalized by Proteins,0.4777121749424532,0.5638358952442705
RB2022_6_RecoveryStrength,0.484678157621895,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,0.5910968683854856
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.4855526104410675,0.6718044272978608
RB2022_7_PreEndurance,0.4958791264127429,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.6064542411391457
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.568935731882125
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,0.49024079076454835,0.6028663033358482
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.47381461692442306,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4867463181313152,0.6532610964053924
SR2019_Hs578T_Biol_repl_4,,0.6234174697589988
RB2022_8_PreStrength,0.4846047846405718,
KS2014_Intensity C5,0.4873760390210692,0.6969040495755952
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,0.6122663073998416
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.4901052457537869,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.5938298226404163
GF2025_P9_Adh,,0.5726524860262078
RB2022_3_PostStrength,0.4847443608560358,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,0.6076862492907835
AH2018_LFQ_M_4_N,,0.5715296359094503
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5891965760094586
AH2018_LFQ_2_X,,0.619795469906857
PG2020_Intensity 2h_B,,0.6291546625344943
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.4845481971032812,
KS2014_Intensity E15_3,,0.6930610712472726
GF2025_P3_Sph,,0.6136606126818424
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.48021074575808387,0.676755997655098
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.48724000892440766,
AS2011_Ratio H/L RNAi_2_3,0.4897368988653364,0.6082496853449212
AH2018_SILAC_IT_1_N,0.49925203966246656,0.684847430113099
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.49119209825278887,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5670463858718192
ZQ2022_N1,,0.5985879287894875
LY2019_P6-,,0.6124052654709321
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.6292822134987165
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,0.5706207390852668
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.6237698247996478
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.6007295988650093
RB2022_1_RecoverySprint,0.484076360626009,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.6195944419140341
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,0.564769360013292
PG2020_Intensity 4h_B,,0.6414756533985219
SR2019_BT549_Biol_repl_2,,0.6154252655167055
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.4733206530487711,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.7198838880845867
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5500684587853958
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.48684437512107326,0.6551087779680091
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.6065919682800733
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.6156526122919787
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.5276068883570898
RB2022_8_PreEndurance,0.48987200301115763,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,0.4777121749424532,0.5638358952442705
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.48893795296138914,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.49770001626733656,
AH2018_SILAC_MR_3_C,,0.637890529105987
AH2018_LFQ_M_4_C,,0.5755003224996548
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,0.6190278264864563
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.5797268301993541
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.7223400395369454
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.5981442351166619
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.7145272878812299
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.48926157921203667,0.663605330373081
GF2025_P10_Adh,,0.5886255562320164
RB2022_1_RecoveryStrength,0.4927578269108688,
SR2019_HCC1954_Biol_repl_4,,0.5972061377192789
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.48583624885579885,0.6385733520966826
RB2022_4_PreSprint,0.4947718942328527,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.48794559710796753,0.647490111390057
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.48191718239747844,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.48224639531280805,0.6769402565795327
LY2019_P8+,,0.6035687816345293
RB2022_2_RecoveryEndurance,0.4960787698150286,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,0.6089344637614604
RB2022_3_PostEndurance,0.46099225825034856,
KS2014_Intensity pY_PV1,,0.6051000194020855
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.6268083492069155
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.47493339833004544,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5841315056768289
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,0.5992547794494296
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.6578171372090335
LY2019_P2-,,0.5945768557111425
AH2018_LFQ_IT_1_X,0.4847154223675658,0.6732655967408298
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,,0.7097956139649222
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.48477864641827706,0.6274536507023677
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.6151889501613437
SR2019_MCF10A_Biol_repl_4,,0.6049668012481378
KS2014_Intensity pY_C5,,0.6097264536441244
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.6700395359131271
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.604671094880556
AH2018_TMTMS3_3_N,0.48701813980977837,0.6380079429992457
SR2019_HCC1419_Biol_repl_2,,0.6374901367331108
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.6362397731300747
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4780372031341712,
KBE2022_Log2_Ex_36_T,,0.6039776236648041
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.7318779338501296
KS2014_Intensity C2,0.4881156809854015,0.7197646366627356
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,0.6719264217861852
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.6738354541865755
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.5893891046178369
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.5788404923135443
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.6932728976765041
ZQ2022_C3,,0.5858313732402375
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.506115386825046,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.7185586240135171
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.5574853686294016
HS2024_5_I_T3,,
KS2014_Intensity N1,0.485629079251164,0.6721329458163167
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.6912756174282008
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.6364386654321232
LATM2013_Log2 Ratio (Medium/Light) Forward,0.47935865061165084,0.564714771422114
PG2020_Intensity 2h_A,,0.5867629004033118
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.6337028589375269
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,0.48019602972311376,0.5745269962918217
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.5882961862753806
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.4825260733547081,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,0.5751836422230638
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,0.5907164823342356
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.7082524800826214
KBE2022_Log2_Ex_29_U,,0.6131079668022681
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5714598360399926
AH2018_LFQ_IT_4_N,,0.6755009713986309
CK2022_15 200-1,,0.671406514745894
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5861446831472034
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.4940973956687397,0.6061754448944744
CK2022_2 200-1,,0.6766746071155288
AS2011_Ratio H/L Protein RNAi_2,0.490580683072454,0.6078751115494224
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.7077733682047892
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,0.5934393385787587
MM2018_Ratio H/L replicate 3,,0.6189119726212257
EP2017_Pervanadate R#1 normalized log2 ratio,0.49584554081988996,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.6746159414078666
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,0.7312210294923865
KS2014_Intensity pY_C6,,0.6079555115714829
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.4905848734306765,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.4893197647616142,0.7096512236926592
FSO2013_Ratio H/M normalized Rep3___1,,0.5919141854022009
AH2018_SILAC_M_3_C,,0.6796449219384183
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.6963760190131607
AH2018_SILAC_M_2_X,,0.6901394338945271
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.721917241493704
PG2020_Intensity 6h_C,,0.6208108520980685
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,0.6034692892196716
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5887221582962203
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.48542093396315805,0.6381904865422964
CK2022_15 16-1,,0.681338098133689
CK2022_3 16-1,,0.6783347797916371
LY2019_P4-,,0.5698199856017553
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,0.5878021165588939
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5621729286838638
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5078799902441302
CK2022_10 16-1,,0.6752932714182825
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.4915995003103597,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.6241762681832551
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4604311459385933,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.6536843798123169
AR2021_L41 10 μM,,0.5606146439802854
CF2017_EOC 2,,0.6431575435647493
RB2022_6_PostEndurance,0.47835803476098054,
AH2018_SILAC_1_N,0.476588637793766,0.6756306261898772
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.6207914088926146
RB2022_7_PreSprint,0.49441311837741636,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.6803170834196974
ZX2022_CB treated Replicate 1,,0.5985715322398248
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.6276846087872247
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.4875835899862941,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.48975343306552793,0.6547591804758199
AR2021_L41 1 μM,,0.5967105713176218
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4875853521668758,0.6465361282651502
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,0.648308177180048
ZX2022_Control Replicate 3,,0.5982438111692193
KS2014_Intensity C4,0.4872534320998002,0.6973626608564927
AS2011_Ratio H/L Inhi_2,,0.5797515552682244
KBE2022_Log2_Ex_18_T,,0.6064550860471317
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.610704686627646
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.586579112091037
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.6742238074470128
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.485135177505385,
AH2018_SILAC_IT_3_C,0.47552822247766874,0.6763615440028596
WZ2023_Pu_025_10min,,0.7002567586010198
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,0.48709333055479603,0.5658840735800269
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5841532973222009
SR2019_JIMT1_Biol_repl_4,,0.5828482650377248
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.6249818556799118
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.733166370262421
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.691120038875319
KS2014_Intensity C6,,0.6918479796055252
ZQ2022_N3,,0.6023138874667232
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.6149299351223284
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.6025973624822537
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.6163126747159615
AH2018_SILAC_IT_2_C,0.48336908191295597,0.674521548740818
CK2022_5 40-1,,0.6199710946340432
AH2018_LFQ_3_X,,0.6188793849795151
UK2020_UA_3,,0.6225929154905212
LY2019_P7-,,0.6005120626773105
GF2025_P5_Adh,,0.5761982734116881
RB2022_1_PostStrength,0.4814576913674998,
JAW2011_Ratio H/L LS1b,,0.564769360013292
FSO2013_Ratio H/L normalized Rep3___1,,0.5907454045321202
SR2019_HCC1954_Biol_repl_3,,0.5997325975909366
CR2017_Ratio Replicate 2.2,,0.5561418918535614
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.6295468174730053
CK2022_11 16-1,,0.6746723452899377
ZQ2022_C1,,0.5935120831714417
CR2017_Ratio Replicate 2.1,,0.5654863820072934
PG2020_Intensity CT_B,,0.6402266364999387
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.6247221516804556
KS2014_Intensity pY_E5_1,,0.6099221505808666
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,0.5626414764998117
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.62123368511662
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5767561834277058
YA2020_Reporter_intensity_Cancer_No.4,,0.6713441798992407
KS2014_Intensity pY_E5_2,,0.6000775405922062
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5498908038434209
RB2022_2_PreEndurance,0.5010937586469506,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.680627680128885
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,0.5926365506221134
RB2022_1_RecoveryEndurance,0.49097323397827114,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4785766507755665,
AH2018_TMTMS2_1_X,0.48683922892060216,0.6439463796041581
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,0.5900411659476678
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,0.593772518176575
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.6800393566917183
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.484716548327819,0.6732813415910099
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.4920568023563078,0.6530731575345846
CF2017_FTE 14,,0.6400535459225093
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.6171014641446316
SR2019_HCC1419_Biol_repl_3,,0.6554150814792356
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.47341799364047066,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5903621892867353
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.4638012185447643,
AS2011_Ratio H/L Normalized RNAi_2_1,0.4897368988653364,0.6082496853449212
